Ameera Shah turned her father's nondescript clinic into one of the largest pathology chains in India.

Prosecutors have described the 48-year-old US citizen as one of the top protein biochemists in the world. She had worked at GlaxoSmithKline's research facility in suburban Philadelphia for about a decade and had become a senior manager.

Flood hit Kerala seeks hike in borrowing limit to 4.5% to raise Rs 10,500 croreBattling its worst flood in nearly a century, Kerala is planning to raise an additional Rs 10,500 crore debt for rehabilitation and rebuilding. To achieve this, the Chief Minister Pinarayi Vijayan today said that his government will ask Centre to raise the ceiling on borrowing for the state to 4.5 per cent of the GDP. The borrowing limit is currently capped at 3 per cent. GSK seeks mid-September bi...

Nestle, Danone and Hindustan Unilever (HUL), among other firms, are reportedly also in the race for GlaxoSmithKline Consumer Healthcare (GSKCH), whose product line-up includes Horlicks, Boost, and Maltova among others.

The stock opened at 6,077 level  on BSE today. It has been gaining for the last two days and has risen 6.97% during the period.

The public health experts asked Amitabh Bachchan to renounce Horlicks like he had Pepsi in 2014 due to the soft drink's health implications on children.

The US FDA recently gave green signal to market IDx-DR, a medical device to detect diabetic retinopathy, a disease in which high blood sugar damages blood vessels in the retina of eyes and leads to the vision loss.

While Horlicks is a brand with a huge heritage and 140-year-old history, it is only strong in a few countries and gets its bulk sales from India.

ICICI Bank board expresses faith in MD and CEO Chanda KochharICICI Bank board has come out in support of its Managing Director and CEO Chanda Kochhar, saying it has full faith and confidence in her and described certain reports against her regarding credit disbursement to Videocon group as \"malicious and unfounded rumours\". ICICI Bank board also reviewed the bank's internal processes for credit approval and found them robust, the private sector lender said in a statement, as r...

Yesterday, Britain's biggest drugs company GlaxoSmithKline (GSK) announced that it will buy the 36.5 per cent stake that Novartis AG owns in their Consumer Healthcare Joint Venture for $13 billion.

The GST rate cut move has come as a relief for many consumers and companies hit hard by the allocation of specific goods to the 28 per cent tax bracket.

Local medical devices makers who  are facing a tough run, as lack of regulations, government support, tax structure and price control are squeezing their margins and growth, besides competition from MNCs.

Over 90 companies had participated in the placement process. Some of top recruiters are: BCG, PWC, Coca-Cola and HCCB, Mondelez, HUL, ITC, P&G, TAS, RB, RPG, Microsoft, Uber and GSK CH.

The list was topped by Banco Santander group executive chairman Ana Botin. GSK CEO Emma Walmsley bagged the second place, followed by Engie CEO Isabelle Kocher at the third slot.

Arun Agarwal, vice president at Authentication Solution Providers Association, tells Chanchal Pal Chauhan about the measures to curb spurious and fake products in the auto industry with the use of latest technology and the new 'mojo tags'.

NGO Medicines Sans Frontiers had challenged the patent claims of Pfizer, calling it way to gain market monopoly. The MSF has argued that Indian firms can supply the same vaccine for much less.